Related Experiment Video
Updated: Jun 23, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
[The multi-target drugs and their design].
1School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, China. fengchao@mails.tjmu.edu.cn
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|May 20, 2009
Summary
Multi-target drugs offer a solution to the limitations of single-target drugs by addressing complex diseases. This paper explores the design of multi-target drugs, including methods like the pharmacophore model.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Drug Design
Context:
- Single-target drugs face limitations due to the complex, multi-factorial nature of disease pathogenesis.
- Reduced bioactivity and increased side effects are common issues with traditional drug development.
- Multi-target drugs are emerging as a promising strategy to overcome these challenges.
Purpose:
- To discuss the challenges and solutions in designing multi-target drugs.
- To present the pharmacophore model as a method for designing multi-target drugs.
- To explore strategies for developing more effective therapeutics.
Summary:
- This paper addresses the limitations of single-target drugs, such as reduced bioactivity and increased side effects, stemming from complex disease mechanisms.
- It proposes multi-target drugs as a viable solution to these challenges.
- The design of multi-target drugs using the pharmacophore model is specifically presented.
Impact:
- Facilitates the development of more effective drugs for complex diseases.
- Offers a strategic approach to drug discovery and development.
- Enhances therapeutic outcomes by addressing multiple disease pathways simultaneously.
More Related Videos
Related Concept Videos
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...